[Immunology in the medical practice. XXIV. Expression of antibodies on bacteriophages; possibilities for in vitro production of human antibodies for any desired application]
- PMID: 10578425
[Immunology in the medical practice. XXIV. Expression of antibodies on bacteriophages; possibilities for in vitro production of human antibodies for any desired application]
Abstract
Although poly- and monoclonal antibodies are successfully applied in research, an expected clinical breakthrough of these reagents so far has not occurred. This can mainly be explained by the animal origin of antibodies, which may lead to a deleterious immune response upon therapeutic use in humans. Moreover, it has been technically demanding to alter the desired affinity, format and effector functions of existing antibodies. Currently, antibody phage-display technology, through construction of large and highly diverse antibody libraries, completely by-passing the immune system, enables the isolation of human antibodies, which can be engineered for every desired application.
Similar articles
-
Optimal construction of non-immune scFv phage display libraries from mouse bone marrow and spleen established to select specific scFvs efficiently binding to antigen.Biochem Biophys Res Commun. 2004 Oct 15;323(2):583-91. doi: 10.1016/j.bbrc.2004.08.131. Biochem Biophys Res Commun. 2004. PMID: 15369791
-
Isolation of monoclonal antibody fragments from phage display libraries.Methods Mol Biol. 2009;502:341-64. doi: 10.1007/978-1-60327-565-1_20. Methods Mol Biol. 2009. PMID: 19082566
-
Phage display for the production of human monoclonal antibodies against human pathogens.New Microbiol. 2004 Oct;27(4):315-28. New Microbiol. 2004. PMID: 15646045 Review.
-
The human combinatorial antibody library HuCAL GOLD combines diversification of all six CDRs according to the natural immune system with a novel display method for efficient selection of high-affinity antibodies.J Mol Biol. 2008 Feb 29;376(4):1182-200. doi: 10.1016/j.jmb.2007.12.018. Epub 2007 Dec 15. J Mol Biol. 2008. PMID: 18191144
-
Molecular considerations for development of phage antibody libraries.J Drug Target. 2012 Apr;20(3):195-208. doi: 10.3109/1061186X.2011.611517. Epub 2011 Sep 27. J Drug Target. 2012. PMID: 21950316 Review.